The award was established to support and encourage brave and innovative achievements that will benefit patients, improve their quality of life and also contribute to the innovative potential of the Czech healthcare and pharmacy. Dr. Mráz was awarded for his publication “miR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1” in the journal Blood.